...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: 250 MACE scenario question

Jan 2019 Corporation Presentation, Slide 20.

BETonMACE Clinical Trial Analysis Points and Time Lines

.

.

5. Top line data will be announced after adjudication completion.  Key subgroup analyses will also be released  if available – Renal & Cognitive function.

6. H2 2019 and beyond – full outcomes, pre-specified endpoint data, safety results, and clinical implications will be reported and published.

Share
New Message
Please login to post a reply